# Pharmacokinetics, Safety, and Tolerability of SYN-020

> **NCT04815993** · PHASE1 · COMPLETED · sponsor: **Theriva Biologics, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Enteritis Caused by Radiation (Disorder)

## Interventions

- **DRUG:** SYN-020 delayed release capsule

## Key facts

- **NCT ID:** NCT04815993
- **Lead sponsor:** Theriva Biologics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2021-05-18
- **Final completion:** 2021-09-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815993, "Pharmacokinetics, Safety, and Tolerability of SYN-020". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04815993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*